<html>

<head>
    <link href="./static/vendor/bootstrap/css/bootstrap.css" rel="stylesheet">
    <link href="./static/css/outliers.css" rel="stylesheet">
    <meta charset="UTF-8">
</head>

<body>
    <div class="container">
        <h1>Static outliers for Aplos Health PCN</h1>
        This is some intro text. Please fill in our feedback <a href="https://docs.google.com/forms/d/e/1FAIpQLSeH4ai_qyetAY4UAgZSWGnYQHkXNr9efFBmQvdrBi5uuXvgnQ/viewform?usp=pp_url&entry.2016356131=%20">survey</a>.

        <h2>Prescribing where Aplos Health PCN is higher than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_high">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=0401010C0&amp;denomIds=4.1.1&amp;selectedTab=summary">Cloral betaine</a><button type="button" data-toggle="collapse" data-target="#table_high_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>7</td>
      <td>Hypnotics</td>
      <td>985</td>
      <td>0.01</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>30.34</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=0401010C0AAAAAA&amp;denomIds=4.1.1&amp;selectedTab=summary" target="_blank">Cloral betaine 707mg tablets : 7</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=0504010U0&amp;denomIds=5.4.1&amp;selectedTab=summary">Proguanil hydrochloride with atovaquone</a><button type="button" data-toggle="collapse" data-target="#table_high_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3</td>
      <td>Antimalarials</td>
      <td>353</td>
      <td>0.01</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>8.60</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=0504010U0BBAAAA&amp;denomIds=5.4.1&amp;selectedTab=summary" target="_blank">Malarone 250mg/100mg tablets : 3</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=130400000&amp;denomIds=13.4&amp;selectedTab=summary">Other topical corticosteroid preparations</a><button type="button" data-toggle="collapse" data-target="#table_high_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>3</td>
      <td>Topical corticosteroids</td>
      <td>2845</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>4.90</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=130400000AABLBL&amp;denomIds=13.4&amp;selectedTab=summary" target="_blank">Propylene glycol 40% in Clobetasol 0.05% cream : 3</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=0504010L0&amp;denomIds=5.4.1&amp;selectedTab=summary">Mefloquine hydrochloride</a><button type="button" data-toggle="collapse" data-target="#table_high_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>1</td>
      <td>Antimalarials</td>
      <td>353</td>
      <td>0.00</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>4.87</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_high_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=0504010L0AAAAAA&amp;denomIds=5.4.1&amp;selectedTab=summary" target="_blank">Mefloquine 250mg tablets : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=0601023AA&amp;denomIds=6.1.2&amp;selectedTab=summary">Vildagliptin</a><button type="button" data-toggle="collapse" data-target="#table_high_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>52</td>
      <td>Other antidiabetic drugs</td>
      <td>2538</td>
      <td>0.02</td>
      <td>0.0</td>
      <td>0.0</td>
      <td>4.52</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_high_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=0601023AAAAAAAA&amp;denomIds=6.1.2&amp;selectedTab=summary" target="_blank">Vildagliptin 50mg tablets : 52</a></div></td></tr></tbody></table>

        <h2>Prescribing where Aplos Health PCN is lower than most</h2>
        <table border="1" class="dataframe table thead-light table-bordered table-sm" id="table_low">
  <thead>
    
    
  <tr><th>BNF Chemical</th>
      <th><abbr title="number of prescribed items containing this chemical">Chemical Items</abbr></th>
      <th>BNF Subparagraph</th>
      <th><abbr title="count of all prescribed items from this subparagraph">Subparagraph Items</abbr></th>
      <th><abbr title="Ratio of chemical items to subparagraph items">Ratio</abbr></th>
      <th><abbr title="Population mean number of chemical items prescribed">Mean</abbr></th>
      <th><abbr title="Standard Deviation">std</abbr></th>
      <th><abbr title="Number of standard deviations prescribeditem count is away from the mean">Z_Score</abbr></th>
      <th>Plots</th>
    </tr></thead>
  
<tbody><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=1306030B0&amp;denomIds=13.6.3&amp;selectedTab=summary">Ivermectin</a><button type="button" data-toggle="collapse" data-target="#table_low_0_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>7</td>
      <td>Topical preparation for rosacea</td>
      <td>15</td>
      <td>0.47</td>
      <td>0.88</td>
      <td>0.12</td>
      <td>-3.50</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_0_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=1306030B0AAAAAA&amp;denomIds=13.6.3&amp;selectedTab=summary" target="_blank">Ivermectin 10mg/g cream : 5</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=1306030B0BBAAAA&amp;denomIds=13.6.3&amp;selectedTab=summary" target="_blank">Soolantra 10mg/g cream : 2</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=0202030S0&amp;denomIds=2.2.3&amp;selectedTab=summary">Spironolactone</a><button type="button" data-toggle="collapse" data-target="#table_low_1_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>328</td>
      <td>Potassium-sparing diuretics and aldosterone antagonists</td>
      <td>681</td>
      <td>0.48</td>
      <td>0.72</td>
      <td>0.10</td>
      <td>-2.51</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_1_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=0202030S0AAATAT&amp;denomIds=2.2.3&amp;selectedTab=summary" target="_blank">Spironolactone 25mg tablets : 233</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=0202030S0AAAUAU&amp;denomIds=2.2.3&amp;selectedTab=summary" target="_blank">Spironolactone 50mg tablets : 54</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=0202030S0AAAVAV&amp;denomIds=2.2.3&amp;selectedTab=summary" target="_blank">Spironolactone 100mg tablets : 38</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=0202030S0AAEGEG&amp;denomIds=2.2.3&amp;selectedTab=summary" target="_blank">Spironolactone 12.5mg tablets : 3</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=0105020A0&amp;denomIds=1.5.2&amp;selectedTab=summary">Budesonide</a><button type="button" data-toggle="collapse" data-target="#table_low_2_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>7</td>
      <td>Corticosteroids</td>
      <td>24</td>
      <td>0.29</td>
      <td>0.72</td>
      <td>0.18</td>
      <td>-2.32</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_2_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=0105020A0AAAAAA&amp;denomIds=1.5.2&amp;selectedTab=summary" target="_blank">Budesonide 3mg gastro-resistant modified-release capsules : 1</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=0105020A0AAACAC&amp;denomIds=1.5.2&amp;selectedTab=summary" target="_blank">Budesonide 3mg gastro-resistant capsules : 5</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=0105020A0AAAFAF&amp;denomIds=1.5.2&amp;selectedTab=summary" target="_blank">Budesonide 9mg modified-release tablets : 1</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=1003020P0&amp;denomIds=10.3.2&amp;selectedTab=summary">Ibuprofen</a><button type="button" data-toggle="collapse" data-target="#table_low_3_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>345</td>
      <td>Rubefacients, topical NSAIDS, capsaicin and poultice</td>
      <td>2089</td>
      <td>0.17</td>
      <td>0.52</td>
      <td>0.16</td>
      <td>-2.25</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
    <tr id="table_low_3_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=1003020P0AAACAC&amp;denomIds=10.3.2&amp;selectedTab=summary" target="_blank">Ibuprofen 5% gel : 85</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=1003020P0AAAIAI&amp;denomIds=10.3.2&amp;selectedTab=summary" target="_blank">Ibuprofen 10% gel : 114</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=1003020P0BDAAAC&amp;denomIds=10.3.2&amp;selectedTab=summary" target="_blank">Ibugel 5% gel : 3</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=1003020P0BDABAI&amp;denomIds=10.3.2&amp;selectedTab=summary" target="_blank">Ibugel Forte 10% gel : 5</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=1003020P0BEAAAH&amp;denomIds=10.3.2&amp;selectedTab=summary" target="_blank">Deep Relief gel : 5</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=1003020P0BGAAAC&amp;denomIds=10.3.2&amp;selectedTab=summary" target="_blank">Fenbid 5% gel : 133</a></div></td></tr><tr>
      <th><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=0202040B0&amp;denomIds=2.2.4&amp;selectedTab=summary">Co-amilofruse (Amiloride hydrochloride/frusemide)</a><button type="button" data-toggle="collapse" data-target="#table_low_4_items" class="btn btn-default btn-xs">&#9776;</button></th>
      <td>16</td>
      <td>Potassium sparing diuretics and compounds</td>
      <td>58</td>
      <td>0.28</td>
      <td>0.70</td>
      <td>0.19</td>
      <td>-2.24</td>
      <td><img class="zoom" src="data:image/png;base64,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"></td>
    </tr>
  <tr id="table_low_4_items" class="collapse"><td colspan="9" class="hiddenRow"><div><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=0202040B0AAAAAA&amp;denomIds=2.2.4&amp;selectedTab=summary" target="_blank">Co-amilofruse 5mg/40mg tablets : 8</a><br><a href="https://openprescribing.net/analyse/#org=pcn&amp;orgIds=U23546&amp;numIds=0202040B0AAABAB&amp;denomIds=2.2.4&amp;selectedTab=summary" target="_blank">Co-amilofruse 2.5mg/20mg tablets : 8</a></div></td></tr></tbody></table>

    </div>
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="https://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</body>

</html>